In this sense, a nonpharmacological strategy to regulate the activity of TMPRSS2 by its endogenous inhibitor plasminogen activator inhibitor-1 (PAI-1) for influenza and coronavirus infections has recently been reported (9). The gene discussed is SERPINE1; the disease is influenza.